相似文献
1
Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome.
Obstet Gynecol Sci. 2020 Jan;63(1):80-86. doi: 10.5468/ogs.2020.63.1.80. Epub 2019 Dec 20.
2
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
3
Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study.
JMIR Res Protoc. 2024 Feb 6;13:e48854. doi: 10.2196/48854.
4
Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
Hum Reprod. 2021 Dec 27;37(1):109-118. doi: 10.1093/humrep/deab232.
5
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.
Hum Reprod. 2017 Aug 1;32(8):1716-1722. doi: 10.1093/humrep/dex239.
6
The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Hum Reprod. 2013 Apr;28(4):1077-83. doi: 10.1093/humrep/det015. Epub 2013 Feb 1.
7
Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
Fertil Steril. 2015 Feb;103(2):537-41. doi: 10.1016/j.fertnstert.2014.10.033. Epub 2014 Nov 20.
8
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
Hum Reprod Update. 2014 May-Jun;20(3):334-52. doi: 10.1093/humupd/dmt061. Epub 2013 Dec 16.
9
The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
Hum Reprod. 2015 Aug;30(8):1927-33. doi: 10.1093/humrep/dev131. Epub 2015 Jun 4.
10
The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
Arch Gynecol Obstet. 2023 Apr;307(4):1083-1090. doi: 10.1007/s00404-022-06874-w. Epub 2022 Dec 24.
引用本文的文献
1
Functional hypothalamic amenorrhoea and polycystic ovarian morphology: a narrative review about an intriguing association.
Hum Reprod Update. 2025 Jan 1;31(1):64-79. doi: 10.1093/humupd/dmae030.
2
Possible cognition changes in women with polycystic ovary syndrome: a narrative review.
Obstet Gynecol Sci. 2023 Sep;66(5):347-363. doi: 10.5468/ogs.22165. Epub 2023 Jun 28.
3
Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome.
Obstet Gynecol Sci. 2023 Jul;66(4):307-315. doi: 10.5468/ogs.23103. Epub 2023 Jun 28.
4
Risk of Gestational Diabetes and Pregnancy-Induced Hypertension with a History of Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study.
J Clin Med. 2023 Feb 21;12(5):1738. doi: 10.3390/jcm12051738.
5
Effects of high-intensity interval training and strength training on levels of testosterone and physical activity among women with polycystic ovary syndrome.
Obstet Gynecol Sci. 2022 Jul;65(4):368-375. doi: 10.5468/ogs.22002. Epub 2022 Apr 21.
6
Serum testosterone levels are positively associated with serum anti-mullerian hormone levels in infertile women.
Sci Rep. 2021 Mar 18;11(1):6336. doi: 10.1038/s41598-021-85915-x.
本文引用的文献
1
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
Hum Reprod. 2018 Sep 1;33(9):1602-1618. doi: 10.1093/humrep/dey256.
2
Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome.
Obstet Gynecol Sci. 2016 Nov;59(6):498-505. doi: 10.5468/ogs.2016.59.6.498. Epub 2016 Nov 15.
3
Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women.
Int J Endocrinol. 2016;2016:3206872. doi: 10.1155/2016/3206872. Epub 2016 Nov 2.
4
Polycystic ovary syndrome.
Nat Rev Dis Primers. 2016 Aug 11;2:16057. doi: 10.1038/nrdp.2016.57.
5
Is the suppressive effect of cyproterone acetate on serum anti-Müllerian-hormone levels in women with polycystic ovary syndrome stronger than under oral contraceptive pill?
Gynecol Endocrinol. 2016 Aug;32(8):612-616. doi: 10.3109/09513590.2016.1145647. Epub 2016 Feb 18.
6
Assessment of Anti-Müllerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome.
J Clin Res Pediatr Endocrinol. 2016 Mar 5;8(1):55-60. doi: 10.4274/jcrpe.2338. Epub 2015 Jan 18.
7
Comparison of two contraceptive pills containing drospirenone and 20 μg or 30 μg ethinyl estradiol for polycystic ovary syndrome.
Int J Gynaecol Obstet. 2016 Feb;132(2):210-3. doi: 10.1016/j.ijgo.2015.06.065. Epub 2015 Nov 6.
8
1-h Postprandial glucose level is related to the serum anti-Müllerian hormone level in women with polycystic ovary syndrome.
Gynecol Endocrinol. 2015 Oct;31(10):815-8. doi: 10.3109/09513590.2015.1056143. Epub 2015 Aug 17.
9
Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome.
Clin Exp Reprod Med. 2014 Jun;41(2):86-91. doi: 10.5653/cerm.2014.41.2.86. Epub 2014 Jun 30.
10
Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Clin Endocrinol (Oxf). 2014 Dec;81(6):899-906. doi: 10.1111/cen.12557. Epub 2014 Sep 1.
Zotero 插件